Coronavirus: DHS Announces New Travel Restrictions on Certain Inbound U.S. Flights and Travelers from China, Including Medical Screening and Quarantine
Client Alert | 2 min read | 02.03.20
New Measures for Rerouting Flights and Passengers from China
The Department of Homeland Security (DHS) announced over the weekend that to combat the spread of the Coronavirus, all flights departing after 5 pm EST on February 2, 2020 from China, and all passengers traveling from China will be routed through one of 11 U.S. airports where they will be required to make first entry and be screened:
- John F. Kennedy International Airport (JFK), New York
- Chicago O’Hare International Airport (ORD), Illinois
- San Francisco International Airport (SFO), California
- Seattle-Tacoma International Airport (SEA), Washington
- Daniel K. Inouye International Airport (HNL), Hawaii
- Los Angeles International Airport, (LAX), California
- Hartsfield-Jackson Atlanta International Airport (ATL), Georgia
- Washington-Dulles International Airport (IAD), Virginia
- Newark Liberty International Airport (EWR), New Jersey
- Dallas/Fort Worth International Airport (DFW), Texas
- Detroit Metropolitan Airport (DTW), Michigan
Note that per DHS notice, the authorization for rerouting to EWR, DFW, and DTW begins February 3, 2020.
Travelers will pay no additional costs for any rerouting. Notably, flight crew, and flights carrying cargo-only are excluded from these new measures.
Screening, Quarantine Requirements Imposed; Foreign Nationals Who Visited China Will Be Denied Entry
These 11 airports will implement the administration’s recently announced Coronavirus screening and quarantine protocol, under which:
- U.S. citizens who have been in Hubei province within 14 days of their return will be subject to up to 14 days of mandatory quarantine.
- U.S. citizens who have been in other areas of mainland China within 14 days of their return will undergo proactive entry health screening and up to 14 days of self-quarantine with health monitoring.
- Foreign nationals (other than immediate family of U.S. citizens, permanent residents, and flight crew) who have traveled in China within 14 days of their arrival will generally be denied entry into the U.S.
These restrictions will have immediate and wide- ranging impacts for businesses operating internationally, particularly those that rely on U.S. citizens and foreign nationals to travel to and from China and the United States. Given the fast-changing nature of this outbreak, multinational companies should continue to seek guidance from counsel to assist their employees, contractors, suppliers, and business visitors as they adjust their international business needs in accordance with applicable laws and regulations.
Contacts
Insights
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument.
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
Client Alert | 8 min read | 12.10.25
Creativity You Can Use: CJEU Clarifies Copyright for Applied Art
Client Alert | 4 min read | 12.10.25
Federal Court Strikes Down Interior Order Suspending Wind Energy Development
